News

Additional previous surgeries and the duration of the SO tamponade had little or no impact

How retinal imaging can provide clinicians a deeper understanding of myopia

The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission

Research findings from Moorfields Eye Hospital also indicate SDD and drusen differ in many factors related to stroke risk

Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies

Bothnia Dystrophy generally presents during early childhood; patients have night blindness, progressive visual loss, and subsequent legal blindness.

A case series illuminates neuro-ophthalmologic manifestations, retinal vascular involvement and other pathologies

Depending on results from the survey for healthcare professionals, a scope expansion for eIFUs could impact ophthalmic devices including contact lenses.

The research team used spectral-domain OCT and OCT angiography imaging to study the changes in the retinal microvasculature in patients

Dr Margaret A. Chang shares data on the port delivery system with ranibizumab, and her strategy for making the most of conferences

Uncertainty during everyday navigation tasks may adversely affect quality of life for patients with glaucoma

Spotlight on the retina specialists who make up the Eye Care Network advisory boards

Businesses in the retina care space tease new technologies and cutting-edge therapeutics

As part of the Barcelona meeting, retina specialists can recognise the awareness day early

Focus on collaboration, career development and innovation

The Ramin Tadayoni Award supports the next generation of retina researchers while paying tribute to a leader in the field

Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells

Michael Goldstein, MD, discusses 12-month safety and efficacy trial data of human corneal endothelial cell therapy, presented at the 2024 ESCRS Congress

The Finnish company shared technical specifications for the ST500

Professor Gerd Auffarth shares patients’ and colleagues’ responses to a new IOL with a monofocal-like dysphotopsia profile

Phase 1 multicentre study data demonstrate early signs of efficacy

The ESCRS Moving Simulator initiative brings surgical training to nations in need

Dr Ribeiro, President of the European Society of Cataract and Refractive Surgeons, previewed the 2024 congress

The non-diffractive, aspheric IOLs are the second generation of BVI’s ISOPURE family

A case report demonstrates independent effect of GLP-1 receptor agonist

Akantior, an anti-amoebic polymer eye drop, is the first and only authorised medical product for the treatment of AK in the world, according to a news release.

The future of the tech-forward surgical suite

A meta-analysis indicates a "significant association" between vitamin D deficiency and increased risk of RVO

Clinical associations, imaging strategies and establishing a differential diagnosis from pseudopapilloedema

The IOL, designed with artificial intelligence, will launch at this year's ESCRS Congress in Barcelona, Spain